General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-07 | 2024-09 | -0.07 | N/A | N/A | N/A |
2024-08-05 | 2024-06 | -0.19 | -0.06 | 0.13 | 68.42% |
2024-05-06 | 2024-03 | -0.23 | -0.17 | 0.06 | 26.09% |
2024-02-26 | 2023-12 | -0.24 | -0.28 | -0.04 | -16.67% |
2023-11-02 | 2023-09 | -0.25 | -0.19 | 0.06 | 24.00% |
2023-08-03 | 2023-06 | -0.25 | -0.24 | 0.01 | 4.00% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-24 | RBC Capital | Upgrade | Outperform | Outperform |
2023-09-17 | RBC Capital | Upgrade | Sector Perform | Outperform |
2023-08-03 | RBC Capital | Upgrade | Sector Perform | Sector Perform |
2023-08-03 | Jefferies | Upgrade | Hold | Buy |
2023-08-03 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-02 | Needham | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-06-11 | ABERCROMBIE GEORGE B | Director | 36.43K | Stock Award(Grant) |
2024-06-11 | ASELAGE STEPHEN J | Director | 72.66K | Stock Award(Grant) |
2024-06-11 | GALSON STEVEN K | Director | 58.37K | Stock Award(Grant) |
2024-06-13 | HEGGIE THERESA | Director | 52.85K | Sale |
2024-06-11 | HUTSON NANCY J | Director | 93.64K | Stock Award(Grant) |
2024-06-11 | LEVIN ALAN G | Director | 51.77K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Blackrock Inc. | 15.50M | 109.09M | 8.18% |
2023-06-29 | Vanguard Group Inc | 15.09M | 106.23M | 7.96% |
2023-06-29 | Baker Brothers Advisors, LLC | 12.71M | 89.48M | 6.71% |
2023-06-29 | State Street Corporation | 12.26M | 86.34M | 6.47% |
2023-06-29 | Avoro Capital Advisors LLC | 12.06M | 84.87M | 6.36% |
2023-06-29 | Assenagon Asset Management S.A. | 5.33M | 37.54M | 2.81% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-08-30 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 8.22M | 58.41M | 4.34% |
2023-06-29 | Vanguard Total Stock Market Index Fund | 5.86M | 41.26M | 3.09% |
2023-08-30 | iShares Russell 2000 ETF | 4.29M | 30.51M | 2.26% |
2023-08-30 | Fidelity Select Portfolios - Biotechnology | 2.81M | 19.96M | 1.48% |
2023-06-29 | Vanguard Extended Market Index Fund | 2.58M | 18.14M | 1.36% |
2023-06-29 | Vanguard Small-Cap Index Fund | 2.44M | 17.17M | 1.29% |
Dividend | Date |
---|---|
0 | 2014-06-11 |
0 | 2014-06-05 |
0 | 2014-05-20 |
0 | 2014-05-16 |
0 | 2014-04-02 |
$BCRX How many out their wish they would have bailed completely back when Bio99 did in the 14.00-!6.00 range and everyone gave him a hard time
$BCRX WHERE IS THA PLUS ?
$BCRX It’s just plain sad!
$BCRX All you Pros don’t forget the PLUS ! You bet buddy.
$BCRX Plus what you clown!
$BCRX I guess we can forget the PLUS huh Jon ?
$BCRX MartinPlante is delusional he’s a mixed up sea turtle SCAM
$BCRX 15 SHARES Pre mkt.
$BCRX Marango give it up buddy spew your loser garbage somewhere else move on!
$BCRX Glad I’ve got a $1.92 avg.
$BCRX this could be the next CCXI….then mabe NOT!
$BCRX News flash we are up $3.03 from 3/15/2018 wow!
$BCRX I mean sell some more.
$BCRX 9 scripts …1.25 scripts per continent Boy we are tearing um up better buy some more shares